Oral Mucositis Case Studies.

Will your patients suffer from Oral Mucositis

Oral mucositis is a common, debilitating side effect of cancer therapy.

97% of patients receiving radiation for head and neck cancer develop oral mucositis28
70% of patients receiving haematopoietic stem cell transplantation develop oral mucositis5
Up to 40% of patients receiving conventional chemotherapy develop oral mucositis5
Patient: Female

Age: 63

Diagnosis: Colorectal cancer

Treatment: 5FU containing regimen

Patient Background: Previously in good health

Development of oral mucositis:

Cycle 1: no oral mucositis

Cycle 2: mild inflammation

Cycle 3: severe oral mucositis, requirement for opioids
Patient: Male

Age: 59

Diagnosis: Tongue cancer

Treatment: Combined radio and chemotherapy

Patient Background: Smoker, high alcohol intake, poor oral hygiene

Development of oral mucositis: 6 weeks intensity-modulated radiation therapy, severe oral mucositis in week 3, unable to eat and drink, requirement for parenteral feeding and opioids
Patient: Female

Age: 51

Diagnosis: Acute lymphoblastic leukaemia (ALL)

Treatment: Conditioning chemotherapy (methotrexate) prior to haematopoietic stem cell transplant (HSCT)

Patient Background: Previously in good health

Development of oral mucositis: Redness and ulceration of the oral mucosa and development of septicaemia 4 days after receiving chemotherapy

 

Real life experiences of oral mucositis:

Julie, 51, leukemia patient31

" I developed these really painful ulcers all over my mouth and throat. They were worse than having cancer, worse than the nausea and hair loss, worse than the transplant. I couldn't eat or drink for weeks because -swallowing was agony; I could barely talk and needed huge doses of morphine for the pain."

Nadine, 56, breast cancer patient32

The pain I suffered from this mouth problem was much worse than the complete mastectomy.

EUSAPharma Caphosol
® Caphosol is a registered trademark of EUSA Pharma.